United StatesSuccinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL) in 25 x 10 mL multiple-dose vials (NDC 43598-666-25), Lot K250048, distributed by Dr. Reddy’s Laboratories, Princeton, NJ (571 vials sold nationwide in the U.S.). It was recalled after an out-of-specification result during 6-month stability testing found decreased preservative concentration.
What's being recalled
Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25
Recalling firm: Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States.
How to identify it
Lot # K250048
The hazard
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide within the USA.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)